Items where authors include "Selby, P"
Article
Brown, JE, Royle, K-L orcid.org/0000-0003-0225-1199, Gregory, W et al. (96 more authors) (2023) Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. The Lancet Oncology, 24 (3). pp. 213-227. ISSN 1470-2045
Savage, R, Messenger, M orcid.org/0000-0002-4975-0158, Neal, RD et al. (12 more authors) (2022) Development and validation of multivariable machine learning algorithms to predict risk of cancer in symptomatic patients referred urgently from primary care: a diagnostic accuracy study. BMJ Open, 12 (4). e053590. ISSN 2044-6055
Mason, SJ, Downing, A orcid.org/0000-0002-0335-7801, Wilding, S orcid.org/0000-0002-7977-7132 et al. (9 more authors) (2022) Stability of health-related quality of life and morbidity burden from 18 months after diagnosis of prostate cancer: results of a UK-wide population-based outcome cohort. Supportive Care in Cancer, 30 (4). pp. 3151-3164. ISSN 0941-4355
Lawler, M, Oliver, K, Gijssels, S et al. (21 more authors) (2021) The European Code of Cancer Practice. Journal of Cancer Policy, 28. 100282. ISSN 2213-5383
Kottke, T, Tonne, J, Evgin, L et al. (19 more authors) (2021) Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy. Nature Communications, 12 (1). 1930. ISSN 2041-1723
Watson, E, Wilding, S orcid.org/0000-0002-7977-7132, Matheson, L et al. (10 more authors) (2021) Experiences of Support for Sexual Dysfunction in Men With Prostate Cancer: Findings From a U.K.-Wide Mixed Methods Study. Journal of Sexual Medicine. ISSN 1743-6095
Smith, L orcid.org/0000-0002-4280-6323, Downing, A orcid.org/0000-0002-0335-7801, Norman, P orcid.org/0000-0002-6211-1625 et al. (12 more authors) (2020) Influence of deprivation and rurality on patient-reported outcomes of men living with and beyond prostate cancer diagnosis in the UK: a population-based study. Cancer Epidemiology, 69. 101830. ISSN 1877-7821
Wilding, S orcid.org/0000-0002-7977-7132, Downing, A orcid.org/0000-0002-0335-7801, Selby, P et al. (13 more authors) (2020) Decision regret in men living with and beyond nonmetastatic prostate cancer in the United Kingdom: A population‐based patient‐reported outcome study. Psycho-Oncology, 29 (5). pp. 886-893. ISSN 1057-9249
Driscoll, CB, Schuelke, MR, Kottke, T et al. (17 more authors) (2020) APOBEC3B-mediated Corruption of the Tumor Cell Immunopeptidome Induces Heteroclitic Neoepitopes for Cancer Immunotherapy. Nature Communications, 11. 790. ISSN 2041-1723
Wilding, S orcid.org/0000-0002-7977-7132, Downing, A orcid.org/0000-0002-0335-7801, Wright, P orcid.org/0000-0001-6129-4143 et al. (10 more authors) (2019) Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy. Quality of Life Research, 28 (10). pp. 2741-2751. ISSN 0962-9343
Selby, P, Liu, L, Downing, A orcid.org/0000-0002-0335-7801 et al. (10 more authors) (2019) How can clinical research improve European health outcomes in cancer? Journal of Cancer Policy, 20. ARTN 100182. ISSN 2213-5383
Wright, P orcid.org/0000-0001-6129-4143, Wilding, S orcid.org/0000-0002-7977-7132, Watson, E et al. (12 more authors) (2019) Key factors associated with social distress after prostate cancer: Results from the United Kingdom Life after Prostate Cancer diagnosis study. Cancer Epidemiology, 60. pp. 201-207. ISSN 1877-7821
Downing, A orcid.org/0000-0002-0335-7801, Wright, P orcid.org/0000-0001-6129-4143, Hounsome, L et al. (23 more authors) (2019) Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study. Lancet Oncology, 20 (3). pp. 436-447. ISSN 1470-2045
Donnelly, DW, Donnelly, C, Kearney, T et al. (26 more authors) (2018) Urinary, bowel and sexual health in older men from Northern Ireland. BJU International, 122 (5). pp. 845-857. ISSN 1464-4096
Selby, P and Velikova, G orcid.org/0000-0003-1899-5942 (2018) Taking patient reported outcomes centre stage in cancer research - why has it taken so long? Research Involvement and Engagement, 4. 25. ISSN 2056-7529
Samson, A orcid.org/0000-0002-3081-7850, Bentham, MJ orcid.org/0000-0003-2439-3198, Scott, K orcid.org/0000-0002-5790-9579 et al. (15 more authors) (2018) Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer. Gut, 67 (3). pp. 562-573. ISSN 0017-5749
Gopalakrishna, G, Langendam, M, Scholten, R et al. (470 more authors) (2017) Erratum to: Methods for evaluating medical tests and biomarkers. Diagnostic and Prognostic Research, 1 (11). pp. 2-5.
Kottke, T, Evgin, L, Shim, KG et al. (12 more authors) (2017) Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence. Cancer Immunology Research, 5 (11). pp. 1029-1045. ISSN 2326-6066
Cockle, JV, Brüning-Richardson, A orcid.org/0000-0002-9862-9805, Scott, KJ orcid.org/0000-0002-5790-9579 et al. (13 more authors) (2017) Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion. Molecular Therapy - Oncolytics, 5. pp. 75-86. ISSN 2372-7705
Gopalakrishna, G, Langendam, M, Scholten, R et al. (468 more authors) (2017) Erratum to: Methods for evaluating medical tests and biomarkers. Diagnostic and Prognostic Research, 1. 11. ISSN 2397-7523
Selby, P, Lawler, M, Baird, R et al. (3 more authors) (2017) The potential consequences for cancer care and cancer research of Brexit. ecancermedicalscience, 11. ed63. ISSN 1754-6605
Lawler, M, Banks, I, Law, K et al. (57 more authors) (2017) The European Cancer Patient’s Bill of Rights, update and implementation 2016. ESMO Open, 2016 (1). e000127. ISSN 2059-7029
Ilett, E, Kottke, T, Thompson, J et al. (12 more authors) (2017) Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumor therapy. Gene Therapy, 24 (1). pp. 21-30. ISSN 0969-7128
Kottke, T, Shim, KG, Alonso-Camino, V et al. (12 more authors) (2016) Immunogenicity of self tumor associated proteins is enhanced through protein truncation. Molecular Therapy - Oncolytics, 3. 16030.
Downing, A orcid.org/0000-0002-0335-7801, Wright, P orcid.org/0000-0001-6129-4143, Wagland, R et al. (24 more authors) (2016) Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study. BMJ Open, 6 (12). e013555. ISSN 2044-6055
Cockle, JV, Rajani, K, Zaidi, S et al. (11 more authors) (2016) Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling. Neuro-Oncology, 18 (4). pp. 518-527. ISSN 1523-5866
Baird, R, Banks, I, Cameron, D et al. (53 more authors) (2016) An Association of Cancer Physicians’ strategy for improving services and outcomes for cancer patients. Ecancermedicalscience, 10. 608.
Zaidi, S, Blanchard, M, Shim, K et al. (13 more authors) (2015) Mutated BRAF emerges as a major effector of recurrence in a murine melanoma model after treatment with immunomodulatory agents. Molecular Therapy, 23 (5). 845 - 856. ISSN 1525-0016
Ilett, E orcid.org/0000-0002-9875-0322, Kottke, T, Donnelly, O et al. (10 more authors) (2014) Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus. Molecular Therapy, 22 (10). pp. 1851-1863. ISSN 1525-0016
Alonso-Camino, V, Rajani, K, Kottke, T et al. (12 more authors) (2014) The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site. Molecular Therapy, 22 (11). 1936 - 1948. ISSN 1525-0016
Jennings, V, Ilett, EJ orcid.org/0000-0002-9875-0322, Scott, K orcid.org/0000-0002-5790-9579 et al. (10 more authors) (2014) Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites. International Journal of Cancer, 134 (5). pp. 1091-1101. ISSN 0020-7136
Kottke, T, Boisgerault, N, Diaz, RM et al. (12 more authors) (2013) Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence. Nature Medicine, 19. 1625 - 1631. ISSN 1078-8956
Boisgerault, N, Kottke, T, Pulido, J et al. (11 more authors) (2013) Functional Cloning of Recurrence-specific Antigens Identifies Molecular Targets to Treat Tumor Relapse. Molecular Therapy, 21 (8). 1507 - 1516. ISSN 1525-0016
Kottke, T, Errington, F orcid.org/0000-0003-2155-534X, Pulido, J et al. (12 more authors) (2011) Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. Nature Medicine, 17 (7). pp. 854-859. ISSN 1078-8956
Steele, L, Errington, F orcid.org/0000-0003-2155-534X, Prestwich, R et al. (7 more authors) (2011) Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune priming. Molecular Cancer, 10 (1). 20. ISSN 1476-4598
Harley, C orcid.org/0000-0002-8800-4238, Adams, J, Booth, L et al. (3 more authors) (2009) Patient Experiences of Continuity of Cancer Care: Development of a new Medical Care Questionnaire (MCQ) for Oncology Outpatients. Value in Health, 12 (8). pp. 1180-1186. ISSN 1098-3015
Wright, P orcid.org/0000-0001-6129-4143, Smith, A, Roberts, K et al. (2 more authors) (2007) Screening for social difficulties in cancer patients: clinical utility of the Social Difficulties Inventory. British Journal of Cancer, 97. pp. 1063-1070. ISSN 0007-0920
Wright, P orcid.org/0000-0001-6129-4143, Smith, A, Booth, L et al. (4 more authors) (2005) Psychosocial difficulties, deprivation and cancer: 3 questionnaire studies involving 609 cancer patients. British Journal of Cancer, 93 (6). pp. 622-626. ISSN 0007-0920
Merrick, AE, Errington, F orcid.org/0000-0003-2155-534X, Milward, K et al. (8 more authors) (2005) Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naïve T-cell priming. British Journal of Cancer, 92 (8). pp. 1450-1458. ISSN 0007-0920
Burchill, SA, Perebolte, L, Johnston, C et al. (2 more authors) (2002) Comparison of the RNA-amplification based methods RT–PCR and NASBA for the detection of circulating tumour cells. British Journal of Cancer, 86 (1). pp. 102-109. ISSN 0007-0920
Cull, A, Gould, A, House, A orcid.org/0000-0001-8721-8026 et al. (5 more authors) (2001) Validating automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice. British Journal of Cancer, 85 (12). pp. 1842-1849. ISSN 0007-0920
Burchill, SA, Lewis, IJ and Selby, P (1999) Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells. British Journal of Cancer, 79 (5-6). pp. 971-977. ISSN 0007-0920
Burchill, SA, Bradbury, MF, Pittman, K et al. (3 more authors) (1995) Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. British Journal of Cancer, 71 (2). pp. 278-281. ISSN 0007-0920
Ward, U, Primrose, JN, Finan, PJ et al. (4 more authors) (1993) The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer. British Journal of Cancer, 67 (5). pp. 1132-1135. ISSN 0007-0920
Selby, P, Patel, P, Milan, S et al. (7 more authors) (1990) ChlVPP combination chemotherapy for Hodgkin's disease: long-term results. British Journal of Cancer, 62 (2). pp. 279-285. ISSN 0007-0920
Lakhani, S, Selby, P, Bliss, JM et al. (3 more authors) (1990) Chemotherapy for malignant melanoma: Combinations and high doses produce more responses without survival benefit. British Journal of Cancer, 61 (2). pp. 330-334. ISSN 0007-0920
Zulian, GB, Selby, P, Milan, S et al. (5 more authors) (1989) High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin’s disease. British Journal of Cancer, 59 (4). pp. 631-635. ISSN 0007-0920
Book Section
Seligmann, J, Messenger, M orcid.org/0000-0002-4975-0158, Seymour, M et al. (1 more author) (2017) Clinical Trials in Precision Oncology. In: Copson, ER, Hall, P, Board, RE, Cook, G and Selby, P, (eds.) Problem Solving Through Precision Oncology: A Case Study Based Reference and Learning Resource. Clinical Publishing , Abingdon, Oxon, UK . ISBN 978-1-84692-111-7
Messenger, M orcid.org/0000-0002-4975-0158, Hall, P, Shinkins, B et al. (3 more authors) (2017) Developing Diagnostic Tests for Precision Oncology. In: Copson, ER, Hall, P, Board, RE, Cook, G and Selby, P, (eds.) Problem Solving Through Precision Oncology A Case Study Based Reference and Learning Resource. Clinical Publishing , Abingdon, Oxon, UK , pp. 67-75. ISBN 978-1-84692-111-7
Proceedings Paper
Brown, JE, Royle, K-L orcid.org/0000-0003-0225-1199, Ralph, C et al. (17 more authors) (2021) STAR: A randomised multi-stage phase II/III trial of standard first-line therapy (sunitinib or pazopanib) comparing temporary cessation with allowing continuation, in the treatment of locally advanced and/or metastatic renal Cancer (RCC). In: Annals of Oncology. ESMO Congress 2021, 16-21 Sep 2021, Paris, France. Elsevier , S1303-S1304.
Downing, A orcid.org/0000-0002-0335-7801, Wright, P orcid.org/0000-0001-6129-4143, Wilding, S orcid.org/0000-0002-7977-7132 et al. (13 more authors) (2018) Patient-reported outcomes in men with advanced and localised disease: Results from the UK-wide Life After Prostate Cancer Diagnosis study. In: British Journal of Cancer. 2018 NCRI Cancer Conference of National Cancer Research Institute, 04-06 Nov 2018, Glasgow. Nature Publishing Group , p. 11.
Birch, R orcid.org/0000-0003-1579-1397, Taylor, J orcid.org/0000-0002-2518-5799, Downing, A orcid.org/0000-0002-0335-7801 et al. (3 more authors) (2018) The management of rectal cancer in older patients in England - a retrospective population based study a patients diagnosed between April 2009 and December 2014. In: European Journal of Surgical Oncology. 38th European Society of Surgical Oncology Congress (ESSO 38), 10-12 Oct 2018, Budapest, Hungary. ESSO .
Gopalakrishna, G, Langendam, M, Scholten, R et al. (468 more authors) (2017) Methods for Evaluating Medical Tests and Biomarkers. In: Diagnostic and Prognostic Research. Methods for evaluating medical tests and biomarkers: Symposium 2016, 19-20 Jul 2016, Birmingham, UK. BMC .
Kottke, T, Rommelfanger, D, Shim, KG et al. (8 more authors) (2016) Escape from Tumor Dormancy Following Gene- or Viro-Therapies Is Mediated by Acquisition of a Phenotype in Which Innate Immune Surveillance Actively Drives Tumor Cell Recurrence. In: Molecular Therapy. 19th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 04-07 May 2016, Washington DC, USA. Nature Publishing Group , S296-S296.
Kottke, T, Shim, KG, Evgin, L et al. (13 more authors) (2016) Immunogenicity of Self Tumor Associated Antigens Is Enhanced Through Protein Truncation. In: Molecular Therapy. 19th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 04-07 May 2016, Washington DC, USA. Nature Publishing Group , S28-S28.
Alonso-Camino, V, Rajani, K, Kottke, T et al. (11 more authors) (2014) The Profile of Tumor Antigens Which Can Be Targeted By Immunotherapy Depends Upon the Tumor's Anatomical Site. In: Molecular Therapy. 7th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), 21-24 May 2014, Washington, DC, USA. Nature Publishing Group , S200-S200.